Hits:1317 , posted at 2023/4/23 12:18

2023年4月16日，为期两天，在苏州举行的“第二届多肽药物产业创新论坛”正式落下帷幕。

本次论坛国内多肽药物科研界、产业界大咖齐聚，针对行业热门的多肽偶联药物、绿色合成工艺、海洋多肽、胰岛素激动剂、多肽放射性核素诊疗、天然多肽药物、双环肽、透皮缓释技术、合成多肽药物杂质、表征分析策略、制剂工艺、杂质来源及控制、GMP规范管理要求等话题进行了深度探讨。

作为本次论坛的支持单位之一，希施生物与现场的专家及合作伙伴进行了深刻友好的交流，荣获大家的广泛认可。

大会发言嘉宾都精心准备了会议报告；从产业发展方向、热门的原创多肽新药、合成多肽工艺、杂质控制、研发思路、真实案例、实践经验等不同维度为与会代表带来了两天的学术盛宴。

CSBio Introduction

CSBio is Global peptide company bringing more than 30 years of technical expertise into the peptide industry which cover three main categories of products and services:
1) peptide CDMO & CMO service -GMP and R&D peptide production, with API peptide production approved by USFDA.
2) Peptide Instrumentation - from R&D up to Large Scale Manufacturing-type synthesizer, Cleavage systems, PreHPLC system, Column packing equipment and peptide production technical support.
3) Peptide raw material -- High Quality Standard Grade and High Grade Fmoc-protected Amino Acid, peptide reagents, coupling reagents, resins and special reagents, supported by relevant validated QC data, stability data and DMF technical documents.
4) DNA/RNA oligonucleotide synthesizers that can be used from research、process development and production.

CSBio (Shanghai) Ltd.

China (Shanghai) Pilot Free Trade Zone, 85 Faladi Road, Building 2,Room 502 ,Shanghai 201210, China

Email:info@csbiochina.com

Tel:+8621-50781653/50781655

Fax:+8621-50781652/021-50781656

Website: www.csbiochina.com www.csbio.com